View in EDS HTML Full Text PDF Full Text

The efficacy of second-line tyrosine kinase inhibitor for patients with metastatic non-clear cell renal cell carcinoma following first-line immune-oncology combination therapy.

Saved in:
Bibliographic Details
Title: The efficacy of second-line tyrosine kinase inhibitor for patients with metastatic non-clear cell renal cell carcinoma following first-line immune-oncology combination therapy.
Authors: Fujita, Kazutoshi1 (AUTHOR) kazufujita2@gmail.com, Matsushita, Yuto2 (AUTHOR), Toyoda, Shingo1 (AUTHOR), Kojima, Takahiro3 (AUTHOR), Yamashita, Shimpei4 (AUTHOR), Taniguchi, Hisanori5 (AUTHOR), Monji, Keisuke6 (AUTHOR), Ishiyama, Ryo7 (AUTHOR), Tatarano, Shuichi8 (AUTHOR), Masui, Kimihiko9 (AUTHOR), Nakamura, Eijiro10 (AUTHOR), Kaneko, Tomoyuki11 (AUTHOR), Kitano, Goshi3 (AUTHOR), Motoshima, Takanobu12 (AUTHOR), Shiraishi13 (AUTHOR), Kira, Satoru14 (AUTHOR), Murashima, Takaya15 (AUTHOR), Hara, Hiroaki16 (AUTHOR), Matsumura17 (AUTHOR), Nishiyama, Naotaka18 (AUTHOR)
Source: World Journal of Urology. 9/26/2024, Vol. 42 Issue 1, p1-8. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:07244983
DOI:10.1007/s00345-024-05252-2